Report Code : BII976 Jan-2022 Healthcare Format : PDF Pages : 208
Biopharmaceutical manufacturing depends heavily on single-use technologies. This is primarily due to the growing demand for SUBs in the manufacturing of abs, which is driven by low investment costs, a low staff requirement, and the elimination of time-consuming changeover procedures. The growing geriatric population, which is more vulnerable to a wide range of medical conditions, is driving up the demand for biopharmaceuticals around the world. The significant growth in emerging countries' pharmaceutical and biopharmaceutical businesses can be attributed to the presence of less stringent regulatory rules as well as low-cost and skilled labor workflows.
One of the major concerns for the forecast period is the development of reliable, accurate, and low-cost sensors to overcome the problem of bioreactor single use. Furthermore, associations among ventures and scholastic organizations have seen a critical rise in the next coming years on the other hand, high costs may be involved in proper waste management of the vast amounts of disposables is expected to hamper the market growth during the forecast period.
According to Business Intelligence Insights “Global Single-use bioreactors Market is expected to grow from USD 3,192.70 million in 2021 to USD 8.50 million by 2030, at a CAGR of 20.70% during the forecast period 2022-2030
The unanticipated outbreak of Covid 19 has had a positive influence on market growth. The global bioreactors market is expected to prosper from the COVID-19 epidemic. The COVID-19 pandemic has caused a burden on the global healthcare system, increasing the demand for vaccines and monoclonal antibodies for the prevention and treatment of corona virus patients. Many studies have been carried out in cell culture media generated in bioreactors. In response to the new coronavirus pandemic, numerous biopharmaceutical companies are rapidly creating vaccinations, and many prominent producers of single-use bioreactors are presently collaborating with companies that are producing or testing vaccines.
Stirred tanks category dominated the market with more than 52% of the market share
In 2021, the market for single- use bioreactors were dominated by stirred tanks as a product type owing increasing adoption of stirred tank SUBs from pilot-scale to large-scale manufacturing. The great inclination for mixed tank SUBs in the development of powerful microbial societies can be credited for a large chunk of this section. SUBs with mixed tanks provide more significant oxygen flow while reducing design challenges such as hotness evacuation, mass exchange, and higher turmoil rates. In addition, the increasing availability of wave-induced single-use bioreactors is expected to boost market growth soon. Furthermore, drug and high-tech product manufacturers announced multibillion-dollar investments to expand their manufacturing capacities, which is a positive factor for the market in this region.
R&D category dominated the market with the largest market share of 47.02%
The mode of application in which single- use bioreactors can be taken are into Process Development, Research and Development (R&D), and Bioproduction. Research and Development (R&D) accounted for the largest market share in 2021. The growing use of disposable reactors on a broad scale, from the lab to the factory, has been aided by significant developments in bioreactor designs, film technologies, sensor systems, and stirring motors. Also, the adoption of single-use bioreactors in process development is an expediting factor for market growth.
By type of cell
By molecule Type
BY END USER
List of Key Players in the Global Single- use bioreactors Market:
World map title will be here...
North America dominated the market with accounted for the largest market share of 36.34% in 2021
In both developed and emerging countries, the North America single- use bioreactorsmarket grew rapidly. This is majorly due to the presence of major operating players and a well-established biopharmaceutical industry in the region. Furthermore, drug and high-tech product manufacturers declared multibillion-dollar investments to expand their manufacturing capacities, which is a positive factor for the growth of the market in this region. Similarly, in coming years, the growth of the single- use bioreactorsmarket is foretold to show a significant increase in use of dietary products, such as, Asia Pacific and Europe.
|Market Size Value in 2021||USD 3,192.70 Million|
|Market Size Value in 2030||USD 8.50 Million|
|Forecast Units||(USD Million)|
|Countries Covered||North America: U.S and Canada Europe: Germany, France, Italy, U.K, Spain, Russia, Rest of Europe APAC: China, Japan, South Korea, India, Australia, South East Asia, Rest of Asia Pacific Latin America: Brazil, Mexico Middle East And Africa: Saudi Arab, South Africa, UAE|
|Segments Covered||By Product, By Type, By type of cell, By molecule Type, By Application, By End User, By Region,|
|Competitive landscape||Leading companies, Competitive strategies and Consumer engagement scope|
|Customization is available||If our report does not contain the information you require, you can contact our experts to have segments created for you. Please contact us at email@example.com if you have any questions|